Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients
Clicks: 306
ID: 266835
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
306 views
56 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #9 of 17 articles by views in Minerva anestesiologica
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The NGAL/hepcidin ratio is more strongly associated with severe AKI than the single biomarkers alone. NGAL and hepcidin, alone or combined as a ratio, were unable to predict progressive AKI in this selected ICU cohort.
| Reference Key |
j2015minervaurinary
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mårtensson J;Glassford NJ;Jones S;Eastwood GM;Young H;Peck L;Ostland V;Westerman M;Venge P;Bellomo R;; |
| Journal | Minerva anestesiologica |
| Year | 2015 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
aged
middle aged
Prospective Studies
biomarkers / blood*
predictive value of tests
pmid:25479470
j mårtensson
n j glassford
r bellomo
acute kidney injury / blood*
acute kidney injury / diagnosis*
critical care / methods*
hepcidins / blood*
lipocalin-2 / blood*
patients
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.